qs-21 has been researched along with quillaic-acid* in 2 studies
2 other study(ies) available for qs-21 and quillaic-acid
| Article | Year |
|---|---|
In vitro evaluation and molecular docking of QS-21 and quillaic acid from Quillaja saponaria Molina as gastric cancer agents.
The cytotoxic mechanism of the saponin QS-21 and its aglycone quillaic acid (QA) was studied on human gastric cancer cells (SNU1 and KATO III). Both compounds showed in vitro cytotoxic activity with IC Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Molecular Docking Simulation; Oleanolic Acid; Quillaja; Saponins; Stomach Neoplasms | 2020 |
Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.
QS-21 is one of the most promising new adjuvants for immune response potentiation and dose-sparing in vaccine therapy given its exceedingly high level of potency and its favorable toxicity profile. Melanoma, breast cancer, small cell lung cancer, prostate cancer, HIV-1, and malaria are among the numerous maladies targeted in more than 80 recent and ongoing vaccine therapy clinical trials involving QS-21 as a critical adjuvant component for immune response augmentation. QS-21 is a natural product immunostimulatory adjuvant, eliciting both T-cell- and antibody-mediated immune responses with microgram doses. Herein is reported the synthesis of QS-21A(api) in a highly modular strategy, applying novel glycosylation methodologies to a convergent construction of the potent saponin immunostimulant. The chemical synthesis of QS-21 offers unique opportunities to probe its mode of biological action through the preparation of otherwise unattainable nonnatural saponin analogues. Topics: Adjuvants, Immunologic; Carbohydrate Sequence; Molecular Sequence Data; Oleanolic Acid; Quillaja; Sapogenins; Saponins; Trisaccharides | 2006 |